Related Experiment Videos
HLA-DRw6 and renal allograft rejection
British Medical Journal (Clinical Research Ed.)
|January 8, 1983
Summary
Patients with HLA-DRw6 positive status are high responders to kidney transplant antigens. For these patients, HLA-DR identical kidney transplants significantly improve graft survival compared to mismatched transplants.
Area of Science:
- Immunogenetics
- Transplantation immunology
- Nephrology
Background:
- Human Leukocyte Antigen (HLA) compatibility is crucial for renal allograft success.
- HLA-DRw6 positivity identifies a subset of patients with distinct immune responses to allografts.
Purpose of the Study:
- To investigate the impact of HLA-DRw6 status on first renal allograft outcomes.
- To evaluate the effectiveness of HLA-DR matching in DRw6-positive versus DRw6-negative recipients.
Main Methods:
- Retrospective analysis of 247 first renal allografts.
- Comparison of graft survival rates between HLA-DRw6-positive (n=74) and DRw6-negative (n=173) recipients.
- Assessment of HLA-DR matching impact within each group.
Main Results:
- One-year graft survival was significantly lower in DRw6-positive (59%) versus DRw6-negative (75%) recipients (p=0.012).
- HLA-DR matching markedly improved one-year survival in DRw6-positive patients (95% for identical vs. 38% for 2-DR mismatched, p=0.009).
- A minimal benefit of HLA-DR matching was observed in DRw6-negative patients (83% vs. 72%, p>0.05).
Conclusions:
- HLA-DRw6-positive patients exhibit poorer renal allograft survival.
- HLA-DR identical kidney transplantation is strongly recommended for DRw6-positive recipients.
- HLA-DR matching is critical for optimizing outcomes in this high-risk patient group.